Stereotaxis Inc (STXS) Stock Analysis

Stereotaxis Inc (STXS) is a publicly traded company in the HEALTHCARE sector. It trades at $1.98, carries a market capitalization of $189.61M. This page summarizes the public market data, fundamentals, and frequently asked questions for STXS, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL INSTRUMENTS & SUPPLIES

Exchange: NYSE MKT

Key Metrics

Market Sentiment

Stereotaxis Inc currently has a Neutral sentiment score of -0.06.

About Stereotaxis Inc

Stereotaxis, Inc. is a leading innovator in robotic magnetic navigation systems, specializing in advanced solutions for the treatment of arrhythmias and coronary artery disease within interventional operating rooms. Headquartered in St. Louis, Missouri, the company focuses on enhancing procedural outcomes and patient safety through its proprietary technology, which is utilized globally in hospitals. With a commitment to improving cardiac care, Stereotaxis continues to expand its market presen...

GNG Research Analysis

GNG Research scores Stereotaxis Inc (STXS) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for STXS.

Frequently Asked Questions

Does STXS pay dividends?

Stereotaxis Inc (STXS) does not currently pay a regular dividend.

What is STXS's market cap?

Stereotaxis Inc (STXS) has a market capitalization of $189.61M with a current stock price of $1.98.